{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:24:38Z","timestamp":1790771078418,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report the first Asian series on stereotactic body radiation (SBRT) for refractory ventricular arrhythmia (VA) in Taiwanese patients. Three-dimensional electroanatomic maps, delayed-enhancement magnetic resonance imaging (DE-MRI), and dual-energy computed tomography (CT) were used to identify scar substrates. The main target volume was treated with a single radiation dose of 25 Gy and the margin volume received 20 Gy using simultaneous integrated boost delivered by the Varian TrueBeam system. Efficacy was assessed according to VA events recorded by an implantable cardioverter-defibrillator (ICD) or a 24-h Holter recorder. Pre- and post-radiation therapy imaging studies were performed. From February 2019 to December 2019, seven patients (six men, one woman; mean age, 55 years) were enrolled and treated. One patient died of hepatic failure. In the remaining six patients, at a median follow-up of 14.5 months, the VA burden and ICD shocks significantly decreased (only one patient with one ICD shock after treatment). Increased intensity on DE-MRI might be associated with a lower risk for VA recurrence, whereas dual-energy CT had lower detection sensitivity. No acute or minimal late adverse events occurred. In patients with refractory VA, SBRT is associated with a marked reduction in VA burden and ICD shocks, and DE-MRI might be useful for monitoring treatment effects.<\/jats:p>","DOI":"10.1038\/s41598-021-89857-2","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T10:03:17Z","timestamp":1620986597000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["First Asian population study of stereotactic body radiation therapy for ventricular arrhythmias"],"prefix":"10.1038","volume":"11","author":[{"given":"Li-Ting","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Ling-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Min","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Yuan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hsin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeun-Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Lee","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jone","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Jeng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"89857_CR1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1056\/NEJMoa071098","volume":"359","author":"JE Poole","year":"2008","unstructured":"Poole, J. E. et al. Prognostic importance of defibrillator shocks in patients with heart failure. N. Engl. J. Med. 359, 1009\u20131017 (2008).","journal-title":"N. Engl. J. Med."},{"key":"89857_CR2","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1016\/j.jacc.2017.10.030","volume":"70","author":"SR Dukkipati","year":"2017","unstructured":"Dukkipati, S. R. et al. Catheter ablation of ventricular tachycardia in structural heart disease: Indications, strategies, and outcomes-part II. J. Am. Coll. Cardiol. 70, 2924\u20132941 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"89857_CR3","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","volume":"31","author":"A Bujold","year":"2013","unstructured":"Bujold, A. et al. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J. Clin. Oncol. 31, 1631\u20131639 (2013).","journal-title":"J. Clin. Oncol."},{"key":"89857_CR4","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"R Timmerman","year":"2010","unstructured":"Timmerman, R. et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303, 1070\u20131076 (2010).","journal-title":"JAMA"},{"key":"89857_CR5","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma, D. A. et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial. Lancet Lond. Engl. 393, 2051\u20132058 (2019).","journal-title":"Lancet Lond. Engl."},{"key":"89857_CR6","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1056\/NEJMoa1613773","volume":"377","author":"PS Cuculich","year":"2017","unstructured":"Cuculich, P. S. et al. Noninvasive cardiac radiation for ablation of ventricular tachycardia. N. Engl. J. Med. 377, 2325\u20132336 (2017).","journal-title":"N. Engl. J. Med."},{"key":"89857_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.118.038261","volume":"139","author":"CG Robinson","year":"2019","unstructured":"Robinson, C. G. et al. Phase I\/II trial of electrophysiology-guided noninvasive cardiac radioablation for ventricular tachycardia. Circulation 139, 313\u2013321 (2019).","journal-title":"Circulation"},{"key":"89857_CR8","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","volume":"123","author":"B Stam","year":"2017","unstructured":"Stam, B. et al. Dose to heart substructures is associated with non-cancer death after SBRT in stage. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 123, 370\u2013375 (2017).","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"89857_CR9","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1118\/1.3438081","volume":"37","author":"SH Benedict","year":"2010","unstructured":"Benedict, S. H. et al. Stereotactic body radiation therapy: The report of AAPM Task Group 101. Med. Phys. 37, 4078\u20134101 (2010).","journal-title":"Med. Phys."},{"key":"89857_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2214\/AJR.19.21187","volume":"213","author":"M Runge","year":"2019","unstructured":"Runge, M. et al. Metal artifact reduction in cardiovascular MRI for accurate myocardial scar assessment in patients with cardiac implantable electronic devices. Am. J. Roentgenol. 213, 555\u2013561 (2019).","journal-title":"Am. J. Roentgenol."},{"issue":"10","key":"89857_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4329\/wjr.v10.i9.100","volume":"2018","author":"E-SH Ibrahim","year":"2018","unstructured":"Ibrahim, E.-S.H. et al. Optimized cardiac magnetic resonance imaging inversion recovery sequence for metal artifact reduction and accurate myocardial scar assessment in patients with cardiac implantable electronic devices. World J. Radiol. 2018(10), 100\u2013107 (2018).","journal-title":"World J. Radiol."},{"key":"89857_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ijrobp.2016.06.2456","volume":"96","author":"SE Samuels","year":"2016","unstructured":"Samuels, S. E. et al. Methods for reducing normal tissue complication probabilities in oropharyngeal cancer: Dose reduction or planning target volume elimination. Int. J. Radiat. Oncol. Biol. Phys. 96, 645\u2013652 (2016).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"89857_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jacep.2018.08.010","volume":"5","author":"J Romero","year":"2019","unstructured":"Romero, J. et al. Combined endocardial-epicardial versus endocardial catheter ablation alone for ventricular tachycardia in structural heart disease: A systematic review and meta-analysis. JACC Clin. Electrophysiol. 5, 13\u201324 (2019).","journal-title":"JACC Clin. Electrophysiol."},{"key":"89857_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.hrthm.2019.09.028","volume":"17","author":"MS Lloyd","year":"2020","unstructured":"Lloyd, M. S. et al. Clinical experience of stereotactic body radiation for refractory ventricular tachycardia in advanced heart failure patients. Heart Rhythm 17, 415\u2013422 (2020).","journal-title":"Heart Rhythm"},{"key":"89857_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ijrobp.2019.04.005","volume":"104","author":"NC Knutson","year":"2019","unstructured":"Knutson, N. C. et al. Radiation therapy workflow and dosimetric analysis from a phase 1\/2 trial of noninvasive cardiac radioablation for ventricular tachycardia. Int. J. Radiat. Oncol. Biol. Phys. 104, 1114\u20131123 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"89857_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.radonc.2016.08.006","volume":"121","author":"T Kataria","year":"2016","unstructured":"Kataria, T. et al. Quantification of coronary artery motion and internal risk volume from ECG gated radiotherapy planning scans. Radiother Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 121, 59\u201363 (2016).","journal-title":"J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"89857_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/europace\/euz133","volume":"21","author":"R Neuwirth","year":"2019","unstructured":"Neuwirth, R. et al. Stereotactic radiosurgery for ablation of ventricular tachycardia. Eurospace 21, 1088\u20131095 (2019).","journal-title":"Eurospace"},{"key":"89857_CR18","first-page":"1088","volume":"21","author":"C Gianni","year":"2020","unstructured":"Gianni, C. et al. Stereotactic arrhythmia radioablation for refractory scar-related ventricular tachycardia. Heart Rhythm 21, 1088 (2020).","journal-title":"Heart Rhythm"},{"key":"89857_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3857\/roj.2015.33.4.265","volume":"33","author":"M-S Kim","year":"2015","unstructured":"Kim, M.-S. et al. Radiobiological mechanisms of stereotactic body radiation therapy and stereotactic radiation surgery. Radiat. Oncol. J. 33, 265\u2013275 (2015).","journal-title":"Radiat. Oncol. J."},{"key":"89857_CR20","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1126\/science.1082504","volume":"300","author":"M Garcia-Barros","year":"2003","unstructured":"Garcia-Barros, M. et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155\u20131159 (2003).","journal-title":"Science"},{"issue":"78","key":"89857_CR21","first-page":"15","volume":"2020","author":"L Widesott","year":"2020","unstructured":"Widesott, L. et al. Proton or photon radiosurgery for cardiac ablation of ventricular tachycardia? Breath and ECG gated robust optimization. Phys. Med. Eur. J. Med. Phys. 2020(78), 15\u201331 (2020).","journal-title":"Phys. Med. Eur. J. Med. Phys."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89857-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89857-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89857-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T08:17:15Z","timestamp":1670055435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-89857-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["89857"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-89857-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"assertion":[{"value":"20 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10360"}}